Literature DB >> 9056390

S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity.

R T Matthews1, L Yang, M F Beal.   

Abstract

Nitric oxide may be a key mediator of excitotoxic neuronal injury in the central nervous system. In the present experiments we found that S-methylthiocitrulline, a relatively selective neuronal nitric oxide synthase (NOS) inhibitor, produced significant neuroprotection against striatal lesions produced by malonate, and the protection was reversed by l-arginine but not by d-arginine. S-Methylthiocitrulline attenuated malonate-induced increases in 2,3- and 2,5-dihydroxybenzoic acid/salicylate and 3-nitrotyrosine/tyrosine, which may be a consequence of peroxynitrite generation. S-Methylthiocitrulline significantly protected against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced depletions of dopamine, 3, 4-dihydroxyphenylacetic acid, and homovanillic acid. These findings provide further evidence that relatively selective inhibitors of neuronal NOS are neuroprotective in vivo and that they might therefore be useful in the treatment of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9056390     DOI: 10.1006/exnr.1996.6406

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  12 in total

1.  Neuroprotective strategies in Parkinson's disease: protection against progressive nigral damage induced by free radicals.

Authors:  C C Chiueh; T Andoh; A R Lai; E Lai; G Krishna
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 2.  Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease.

Authors:  Derek A Drechsel; Manisha Patel
Journal:  Free Radic Biol Med       Date:  2008-03-04       Impact factor: 7.376

Review 3.  Neurodegeneration and neuroprotection in Parkinson disease.

Authors:  Stanley Fahn; David Sulzer
Journal:  NeuroRx       Date:  2004-01

Review 4.  Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.

Authors:  Bin Liu
Journal:  AAPS J       Date:  2006-09-29       Impact factor: 4.009

5.  A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.

Authors:  M I Colado; J Camarero; A O Mechan; V Sanchez; B Esteban; J M Elliott; A R Green
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

6.  Prospects for redox-based therapy in neurodegenerative diseases.

Authors:  A L Friedlich; M F Beal
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

7.  Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity.

Authors:  Elena Puerta; Isabel Hervias; Beatriz Goñi-Allo; Steven F Zhang; Joaquín Jordán; Anatoly A Starkov; Norberto Aguirre
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

8.  Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.

Authors:  Y Muramatsu; R Kurosaki; T Mikami; M Michimata; M Matsubara; Y Imai; H Kato; Y Itoyama; T Araki
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

Review 9.  Nitric oxide and MPP+-induced hydroxyl radical generation.

Authors:  T Obata
Journal:  J Neural Transm (Vienna)       Date:  2006-02-06       Impact factor: 3.575

10.  Modulation of the ASK1-MKK3/6-p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate.

Authors:  L Barros-Miñones; L Orejana; B Goñi-Allo; V Suquía; I Hervías; N Aguirre; E Puerta
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.